These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17356795)

  • 1. Relationship between diet and anticoagulant response to warfarin: a factor analysis.
    Custódio das Dôres SM; Booth SL; Martini LA; de Carvalho Gouvêa VH; Padovani CR; de Abreu Maffei FH; Campana AO; Rupp de Paiva SA
    Eur J Nutr; 2007 Apr; 46(3):147-54. PubMed ID: 17356795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects.
    Sokoll LJ; Booth SL; O'Brien ME; Davidson KW; Tsaioun KI; Sadowski JA
    Am J Clin Nutr; 1997 Mar; 65(3):779-84. PubMed ID: 9062529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary and nondietary determinants of vitamin K biochemical measures in men and women.
    McKeown NM; Jacques PF; Gundberg CM; Peterson JW; Tucker KL; Kiel DP; Wilson PW; Booth SL
    J Nutr; 2002 Jun; 132(6):1329-34. PubMed ID: 12042454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 8. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
    Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
    J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio.
    Byrd DC; Stephens MA; Hamann GL; Dorko C
    Am J Health Syst Pharm; 1999 Nov; 56(22):2312-5. PubMed ID: 10582823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does fasting during Ramadan influence the therapeutic effect of warfarin?
    Sridharan K; Al Banna R; Qader AM; Husain A
    J Clin Pharm Ther; 2021 Feb; 46(1):86-92. PubMed ID: 32926452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring cohort.
    Braam L; McKeown N; Jacques P; Lichtenstein A; Vermeer C; Wilson P; Booth S
    J Am Diet Assoc; 2004 Sep; 104(9):1410-4. PubMed ID: 15354158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fasting on warfarin sensitivity index in patients undergoing cardiovascular surgery.
    Katada Y; Nakagawa S; Nishimura A; Sato YK; Taue H; Matsumura K; Yamazaki K; Minakata K; Yano I; Omura T; Imai S; Yonezawa A; Sato Y; Nakagawa T; Minatoya K; Matsubara K
    Eur J Clin Pharmacol; 2019 Apr; 75(4):561-568. PubMed ID: 30460405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients.
    Davies BE; Aceves Baldó P; Lennon-Chrimes S; Brewster M
    Br J Clin Pharmacol; 2010 Dec; 70(6):834-43. PubMed ID: 21175439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
    Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
    Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic monitoring of warfarin: the appropriate response marker.
    Costa IM; Soares PJ; Afonso M; Ratado P; Lanaot JM; Falcão AC
    J Pharm Pharmacol; 2000 Nov; 52(11):1405-10. PubMed ID: 11186249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation.
    Nee R; Doppenschmidt D; Donovan DJ; Andrews TC
    Am J Cardiol; 1999 Jan; 83(2):286-8, A6-7. PubMed ID: 10073841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in a national sample of British elderly people.
    Thane CW; Bates CJ; Shearer MJ; Unadkat N; Harrington DJ; Paul AA; Prentice A; Bolton-Smith C
    Br J Nutr; 2002 Jun; 87(6):615-22. PubMed ID: 12067432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study.
    Lubetsky A; Yonath H; Olchovsky D; Loebstein R; Halkin H; Ezra D
    Arch Intern Med; 2003 Nov; 163(20):2469-73. PubMed ID: 14609783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.